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Purpose: Over the last decade, K-DOQI guidelines have increasingly emphasized the importance of autogenous arterio-
venous fistulas (AVF) for dialysis access. A complication of AVF is aneurysmal dilatation with a subset developing massive
diffuse aneurysm. Treatment of massive aneurysmal AVF generally involves either ligation or resection with use of
prosthetic interposition. To maintain an all-autogenous access, we developed a procedure to treat massive aneurysmal
AVF in which the luminal diameter is reduced, excess length is resected, and the new reconstructed AVF is re-tunneled for
continued use. The purpose of this study is to examine the midterm outcomes of this novel procedure.
Methods:Over a 4-year period, the reduction/revision procedure was performed on 19 patients with an AVF diameter of
4-7 cm. Indications for operation were thrombosis, skin breakdown, infection, bleeding, and/or poor flow. Revision was
performed by resecting redundant length, reducing diameter, and then reconstructing the fistula.
Results: The median patient age was 47, interquartile range (IQR) 29. There were 13 men and 6 women. The median
follow-up was 23 months, IQR 22. The median primary patency was 14 months, IQR 24. The median secondary patency
was 16.5 months, IQR 26. Two patients died, one AVF thrombosed, and two were ligated secondary to infection. Three
fistulae developed a stenosis that was treated with percutaneous angioplasty. There are no recurrent aneurysms to date.
Conclusion: Surgical resection of excess length, reduction of luminal diameter, and reconstruction is a viable option for the
treatment of complicated massive diffusely aneurysmal AVF. This technique offers the ability to maintain the benefits of
an all autogenous dialysis access while conserving future dialysis sites. ( J Vasc Surg 2010;51:921-5.)Over the last decade, K-DOQI guidelines have increas-
ingly emphasized the importance of autogenous arterio-
venous fistula (AVF) for dialysis access. A poorly defined
complication of AVF is aneurysm formation. The incidence
of aneurysm formation in autogenous arteriovenous fistula
(AVF) is reported to be as high as 30%, the majority of
which occur in the upper arm.1 The sequelae of aneurysm
formation in AVF include skin breakdown, bleeding, rup-
ture, thrombosis, poor flow resulting in inadequate dialysis,
and infection.
K-DOQI guidelines recommend that intervention be
performed on aneurysmal AVF and that aneurysmal AVF
segments should not be cannulated.2 Treatment strategies
for AVF aneurysms include ligation, placement of pros-
thetic interposition, or more recently, use of percutaneous
stent grafts. The aneurysms described in most reports using
these techniques are focal or are pseudoaneurysms. There
is, however, a subset of dialysis patients with diffuse, mas-
sive, and tortuous aneurysmal dilatation of their AVF who
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doi:10.1016/j.jvs.2009.10.122present a unique challenge. In an effort to maintain an
all-autogenous access, we developed a procedure to treat
diffusely aneurysmal AVF in which the luminal diameter is
reduced, excess length is resected, and the newly recon-
structed AVF is re-tunneled for continued use. The pur-
pose of this study is to examine the midterm outcomes of
this novel procedure. To our knowledge, this specific tech-
nique has not been reported previously in the literature.
METHODS
A retrospective review was performed of all reduction/
reconstruction procedures performed at Kaiser Foundation
Hospital in SanDiego, California. Data abstracted included
patient demographics, postoperative complications and pa-
tency. Patients were contacted by telephone to assess
whether they are currently using the reconstructed fistula
and if they are happy with the results of the procedure.
Patients were evaluated preoperatively with a venogram
to detect any central outflow stenoses contributing to the
aneurysmal dilatation. Percutaneous treatment of an iden-
tified central stenosis was performed on two patients pre-
operatively. A tunneled hemodialysis catheter was placed at
the time of the operation and used until the operative site
healed.
Fifteen of the procedures were performed under gen-
eral anesthesia and four were performed under local anes-
thesia with sedation. Early in the experience, the procedure
was performed under local anesthesia with sedation in the
same manner as we perform our primary dialysis access
procedures. However, due to the length of the procedure
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thesia for patient comfort.
A skin incision was made along the length of the
aneurysmal fistula. The aneurysmal fistula was then circum-
ferentially dissected out from the arterial anastomosis to a
point where the fistula became normal in diameter. (Fig 1,
A) Heparin, 5000 units, was given intravenously. Proximal
and distal control of the fistula was obtained using vascular
clamps. The aneurysmal fistula was then opened longitudi-
nally along its entire length. The excess length secondary to
the tortuosity of the aneurysmal fistula was resected. (Fig 1,
B) A back wall anastomosis was constructed using a 6-0
prolene suture in a running fashion. To construct a fistula
that was 8-10 mm in diameter, a 20F red rubber catheter
was inserted into either end of the fistula. Using the cath-
eter as a guide, the excess wall of the fistula was resected.
The fistula was then reconstructed over the catheter again
using 6-0 prolene suture. (Fig 1, C) The suture line was
created on the lateral aspect of the reconstructed fistula in
order to avoid repeated puncture of the suture line when
the fistula is used for dialysis. A new tunnel was created for
the fistula. The excess skin over the fistula was resected. (Fig
Fig 1. A, Circumferential dissection. B, Resection of ex
excess skin.1, D) Any areas of skin breakdown or thinning of the skinwere included in the excision. Finally, the skin was closed in
two layers using absorbable sutures and a subcuticular skin
closure.
Patients were followed postoperatively by the vascular
surgeon until the wound was healed. Once the wound was
adequately healed, hemodialysis through the fistula was
resumed. The tunneled catheter was removed when suc-
cessful hemodialysis through the fistula was achieved.
RESULTS
Over a 4-year period, the reduction/revision proce-
dure was performed on 19 patients. The median age was 47
years, interquartile range (IQR) 29. Thirteen (68%) of the
patients were male. Sixteen (84%) of the fistulas were in the
upper arm; two were basilic transpositions and 14 were
brachiocephalic AVF. There was one forearm basilic vein
transposition and two Brescia-Cimino wrist fistulas. Over
the 4 years of the study, 942 dialysis access procedures were
performed by our group. No aneurysmal fistulas were man-
aged via other approaches during the 4 years of the study.
During the study period there were two patients at the
beginning of the experience who had diffusely aneurysmal
ength. C, Reconstruction over catheter.D, Resection ofcess lfistulas that were not offered this procedure because not all
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procedure. There were no instances where the procedure
was attempted but then abandoned.
The median number of years since the original fistula
creation was 4 years, IQR 3. The indication for operation
was bleeding in four (21%) and skin breakdown in ten
(53%). Two patients had infected segments of the aneurys-
mal fistula with prurulent drainage. During the procedure
the infected segments were resected and the surrounding
tissue debrided. Nine (47%) of the patients had a history of
renal transplant.
The mean and median operative time was 188 minutes
and 171 minutes, respectively. The mean estimated blood
loss was 268 cc with a range of 50 to 1000 cc. The median
follow up was 23 months, IQR 22. The median primary
patency was 14months, IQR 24. (Appendix I , online only)
The median secondary patency was 16.5 months, IQR 26.
(Appendix II, online only) The mean and median postop-
erative length of stay was 1.1 days and 1 day, respectively.
The mean and median time to removal of tunneled hemo-
dialysis catheter was 10 weeks and 8 weeks, respectively.
One of the two patients who had an infected fistula
preoperatively had bleeding and infection in the 30-day
postoperative period, requiring resection of the fistula.
There were no mortalities in the 30-day postoperative
period. During the follow-up period, three patients re-
quired percutaneous angioplasty of an outflow stenosis to
maintain patency. These interventions occurred at nine, 15,
and 30 months postoperatively.
One patient underwent three operative interventions
resulting in eventual abandonment. This particular patient
had an aneurysmal upper arm brachiocephalic AVF with a
stenosis of the cephalic arch that had failed angioplasty on
multiple occasions. As part of the reduction and revision
operation, the cephalic vein was transected at the shoulder
level, re-tunneled into the axilla, and anastomosed to the
axillary vein. Subsequent recurrent stenoses were all located
at the veno-veno anastomosis. Despite repeated interven-
tions, the fistula failed 16 months postoperatively and was
abandoned.
There was one late thrombosis that occurred 15
months postoperatively, felt to be secondary to hypoten-
sion from cardiac failure. One late infection occurred at 27
months and required fistula ligation. There were two late
deaths that were not related to the fistula. Three patients
are no longer in the Kaiser Permanente system and were
lost to follow-up. Of the remaining 11 patients that are
alive and being followed, all have functional fistulas and
there are no recurrences to date. All patients with func-
tional fistulas stated that they were happy with the results of
the procedure.
DISCUSSION
Hemodialysis, peritoneal dialysis, and renal transplant
are the only life-saving interventions that are available to
patients with renal failure. The number of patients requir-
ing a renal transplant continues to increase faster than the
number of available donors and the median wait time toreceive a renal transplant is 4 years.3 The result is that there
are nearly 400,000 patients in the United States who
require hemodialysis.4 Furthermore, the NKF-DOQI
guidelines state that in 2009, the percentage of patients
using AVF for hemodialysis should be 65%.2
Although AVF is the preferred method of access for
hemodialysis, AVF is not without complications. The most
frequent complications of AVF are aneurysm formation,
neurologic disorder, and vascular steal syndrome.1 The
incidence of aneurysm formation in AVF has been reported
to be as high as 30%.1 When AVF become aneurysmal and
tortuous, cannulation can become difficult and flows can be
compromised due to thrombus formation in the aneurysm.
Other sequelae of aneurysmal degeneration are breakdown
of the overlying skin with the associated risks of bleeding
and infection. In addition, from a quality of life perspective,
patients report being bothered by the appearance of the
fistula more than any other symptom including pain, bleed-
ing, and bruising.5
As a result, NKF-DOQI guidelines state that interven-
tion on a fistula should be performed for the presence of
aneurysm formation and that the aneurysmal segment
should not be cannulated. The literature describes various
techniques of surgical as well as endovascular solutions to
address these aneurysms. However, the techniques de-
scribed are largely for focal aneurysms and pseudoaneu-
rysms. The patients in our series have diffuse and massively
aneurysmal fistulas, an entity that is not well characterized
in the literature.
One described etiology of AVF aneurysms is repeated
puncture at the same site.6 The aneurysms described in this
series, however, are not focal and do not appear to be
entirely related to repeated puncture. Another proposed
mechanism for development of these aneurysms is venous
hypertension secondary to central stenosis or outflow ste-
nosis. Yet, less than 20% of the patients in our series had an
outflow stenosis identified.
Interestingly, there were multiple patients in our series
whose AVF developed diffuse aneurysmal dilation prior to
the AVF being used. These patients were all renal transplant
patients with failing or failed transplants. In fact, 47% of the
patients in our series had a history of renal transplantation.
We speculate that there may be an association between
immunosuppression and fistula aneurysm formation. An
association has been previously described in relation to
immunosuppression and abdominal aortic aneurysm
(AAA) enlargement. A series examining 1500 heart, liver,
and kidney transplant patients demonstrated that while the
incidence of AAA in the transplant patients was no different
from the normal population, the rate of growth and rupture
was significantly higher.7
The treatment of focal fistula aneurysms has tradition-
ally involved resection of the aneurysm with interposition
bypass grafting using prosthetic graft.8,9 There is one case
report of a diffusely enlarged fistula that was treated in this
manner.10 This technique conserves future access sites, but
at the same time, converts an autogenous fistula into a graft.
For localized aneurysms, resection with re-establishment of
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nique, however, is not applicable to the patient population
described in this series.
More recently, covered stents have been described for
the treatment of pseudoaneurysms and aneurysms. Al-
though the use of stent grafts has largely been in the
treatment of hemodialysis-graft related pseudoaneurysms
and aneurysms, there are also reports of stent graft use in
AVF related pseudoaneurysms.12-16 Again, while this pre-
serves the access site, it essentially converts the AVF into a
graft. In addition, the use of stent grafts in our population
is not feasible due to the diffuse dilation of the fistulas to
over 4 cm in diameter and the extension of the aneurysms
up to the arterial anastomosis, thus eliminating any landing
zone.
There are reports of various techniques of aneurysmor-
rhaphy, several of which involve the use of gastrointestinal
anastomosis (GIA) staplers.17,18 The staple line in these
reports is reinforced with a layer of prolene suture. One of
these series reported the results of 12 patients, two of which
had diffuse aneurysms with the remainder being small, less
than 2.0 cm in diameter aneurysms.18 The patients in this
series had a mean follow-up of 25 months with 85% of the
reconstructed fistulas remaining patent throughout the
follow-up period. The same series also reported recurrences
in two patients, one of which required a total of three
operations for aneurysm. Our technique does not require
the use of the staplers, and we have no known recurrences
to date with a similar patency rate.
A technique of plication has also been employed in the
treatment of aneurysmal fistulas.19 In this technique, the ex-
cess wall is plicated by running a prolene suture along the
whole length and back. This resulted in some shrinkage of
the fistula after surgery. However, one of the important
benefits of our operation is the cosmetic improvement. The
patients in our series endured gawking in public as well as
difficulty in fitting their arms into the sleeves of their
clothing due to the massive size of their aneurysms. The
cosmetic improvement resulting from complete excision of
the excess aneurysm wall as well as excess skin has resulted
in a high level of postoperative patient satisfaction in our
series. (Fig 2, A and B).
Other authors have described a technique of pseudo-
aneurysm repair using aneurysmorrhaphy and an external
patch of polyethylene terephthalate to reinforce the suture
line.20 In our practice we have not used this technique as we
employ a very aggressive approach towards creation of
all-autogenous accesses. We have not seen any aneurysmal
degeneration of the suture line as a result of not reinforcing
the suture line.
The procedure that we have developed and described in
this series is a novel and highly successful approach to the
problem of diffuse aneurysmal change in AVF for dialysis.
The primary disadvantage of the procedure is the extent of
the dissection required and the need for a temporary tun-
neled catheter. Despite these concerns, the procedures are
very well tolerated, require minimal hospitalization, havefew wound problems and allow removal of the catheter
within a mean of 10 weeks.
There are no recurrences of the aneurysms to date,
however, the median follow-up of 23 months is short,
relative to the median time of 4 years from initial operation
to revision procedure. There is a possibility that with fur-
ther follow-up the aneurysms could recur. Of note, there is
also a wide range of initial onset of aneurysmal dilation with
some occurring as early as less than 1 year after the initial
fistula creation. It is possible that the scar tissue resulting
from the extensive dissectionmay be a factor in diminishing
recurrence of the aneurysm. Long-term follow-up is re-
quired to definitively answer this question.
CONCLUSION
Surgical resection of excess length, reduction of lumi-
nal diameter, and reconstruction is a viable option for the
treatment of complicated diffusely aneurysmal AVF. Mid-
term results of this novel procedure demonstrate acceptable
patency and complication rates. This technique offers the
ability to maintain the benefits of an all-autogenous dialysis
access while conserving future dialysis sites.
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April 2010925.e1 Woo et alAppendix I (online only). Life table estimates of
primary patency rates
Time (months) n
Survival distribution
function estimate
Standard
error
0 19 1.000 0
3 14 1.000 0
6 14 1.000 0
9 13 0.929 0.069
12 10 0.929 0.069
15 9 0.929 0.069
18 7 0.929 0.069
21 7 0.929 0.069
24 6 0.929 0.069
27 5 0.929 0.069
30 3 0.929 0.069
33 3 0.929 0.069
36 3 0.929 0.069Appendix II (online only). Life table estimates of
secondary patency rates
Time (months) n
Survival distribution
function estimate
Standard
error
0 19 1.000 0
3 14 1.000 0
6 14 1.000 0
9 14 1.000 0
12 11 1.000 0
15 10 1.000 0
18 7 0.889 0.105
21 7 0.889 0.105
24 6 0.889 0.105
27 5 0.889 0.105
30 3 0.889 0.105
33 3 0.889 0.105
